Garcia-Pardo Javier, Tanco Sebastian, Díaz Lucía, Dasgupta Sayani, Fernandez-Recio Juan, Lorenzo Julia, Aviles Francesc X, Fricker Lloyd D
Institut de Biotecnologia i Biomedicina and Departament de Bioquimica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
VIB-UGent Center for Medical Biotechnology, Ghent, Belgium.
PLoS One. 2017 Nov 13;12(11):e0187778. doi: 10.1371/journal.pone.0187778. eCollection 2017.
Metallocarboxypeptidase D (CPD) is a membrane-bound component of the trans-Golgi network that cycles to the cell surface through exocytic and endocytic pathways. Unlike other members of the metallocarboxypeptidase family, CPD is a multicatalytic enzyme with three carboxypeptidase-like domains, although only the first two domains are predicted to be enzymatically active. To investigate the enzymatic properties of each domain in human CPD, a critical active site Glu in domain I and/or II was mutated to Gln and the protein expressed, purified, and assayed with a wide variety of peptide substrates. CPD with all three domains intact displays >50% activity from pH 5.0 to 7.5 with a maximum at pH 6.5, as does CPD with mutation of domain I. In contrast, the domain II mutant displayed >50% activity from pH 6.5-7.5. CPD with mutations in both domains I and II was completely inactive towards all substrates and at all pH values. A quantitative peptidomics approach was used to compare the activities of CPD domains I and II towards a large number of peptides. CPD cleaved C-terminal Lys or Arg from a subset of the peptides. Most of the identified substrates of domain I contained C-terminal Arg, whereas comparable numbers of Lys- and Arg-containing peptides were substrates of domain II. We also report that some peptides with C-terminal basic residues were not cleaved by either domain I or II, showing the importance of the P1 position for CPD activity. Finally, the preference of domain I for C-terminal Arg was validated through molecular docking experiments. Together with the differences in pH optima, the different substrate specificities of CPD domains I and II allow the enzyme to perform distinct functions in the various locations within the cell.
金属羧肽酶D(CPD)是反式高尔基体网络的一种膜结合成分,通过胞吐和胞吞途径循环至细胞表面。与金属羧肽酶家族的其他成员不同,CPD是一种具有三个羧肽酶样结构域的多催化酶,尽管预计只有前两个结构域具有酶活性。为了研究人CPD中每个结构域的酶学性质,将结构域I和/或II中的关键活性位点Glu突变为Gln,并对表达、纯化后的蛋白质用多种肽底物进行检测。具有完整三个结构域的CPD在pH 5.0至7.5范围内显示出>50%的活性,在pH 6.5时达到最大值,结构域I发生突变的CPD也是如此。相比之下,结构域II突变体在pH 6.5 - 7.5范围内显示出>50%的活性。结构域I和II都发生突变的CPD对所有底物在所有pH值下均完全无活性。采用定量蛋白质组学方法比较CPD结构域I和II对大量肽的活性。CPD从一部分肽上切割C末端的Lys或Arg。结构域I鉴定出的大多数底物含有C末端Arg,而含有Lys和Arg的肽作为结构域II底物的数量相当。我们还报告说,一些具有C末端碱性残基的肽既不被结构域I也不被结构域II切割,这表明P1位置对CPD活性的重要性。最后,通过分子对接实验验证了结构域I对C末端Arg的偏好。连同最适pH值的差异,CPD结构域I和II不同的底物特异性使该酶能够在细胞内的不同位置发挥不同的功能。